Tobacco-related cancers and cervical cancers caused most cancer deaths Cancer killed 5,56,400 people across the country in 2010. The 30-69 age group accounted for 71 per cent (3,95,400) of the deaths. In 2010, cancer alone accounted for 8 per cent of the 2.5 million total male deaths and 12 per cent of the 16 million total female deaths in this age group. These are some of the findings of a paper published...

It is a myth that cancer is prevalent only in urban areas More than 5,56,000 cancer deaths occurred in India in 2010 and 71.1 per cent of those who died were aged between 30 and 69 years, says a report on cancer mortality in India, published in the March 28 issue of The Lancet. While men in the age group of 30-69 years are more likely to die of oral cancers followed...

The risk of dying from cancer is highest in the Northeast and the lowest in Bihar, Jharkhand and Orissa, according to a new study described as the first to provide direct nationally-representative estimates of cancer deaths across the country. The study by researchers at the Centre for Global Health Research at the University of Toronto, Canada, and Indian institutions has shown large variations in cancer risk across the states, but suggests...

A new study looking at cancer mortality in 2010 in India found a high 71 per cent (3,95,400) deaths in people between 30 and 69 years. Cancer accounted for 8 per cent of the 2·5 million total male deaths and 12 per cent of the 1·6 million total female deaths in the same age group. The high mortality rate during the middle age is very different from the developed countries,...

-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.   The German pharmaceutical company Bayer holds the patent...